Mahallawi Waleed
Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
Front Med (Lausanne). 2020 Sep 25;7:564264. doi: 10.3389/fmed.2020.564264. eCollection 2020.
The COVID-19 pandemic caused by SARS CoV-2 is a worldwide emergency, and is taking a substantial toll on human health, lives, and the global economy. Due to the novelty of this virus, no SARS CoV-2-specific treatments or licensed vaccines are available though few vaccines are undergoing clinical trials. Therefore, continued research into an effective vaccine is an urgent necessity. The reinfection of recovered patients is one of the major concerns of healthcare providers worldwide. Health authorities are currently seeking evidence of protection from reinfection in recovered individuals. This is the first case report in Saudi Arabia on a patient who was diagnosed as COVID-19-positive; recovered; and after successful recovery was protected against reinfection.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病疫情是一场全球紧急事件，正在对人类健康、生命和全球经济造成巨大损失。由于这种病毒的新颖性，目前尚无针对SARS-CoV-2的特效治疗方法或获批疫苗，不过有少数疫苗正在进行临床试验。因此，继续开展有效疫苗的研究迫在眉睫。康复患者再次感染是全球医疗服务提供者主要关注的问题之一。卫生当局目前正在寻找康复个体免受再次感染的证据。这是沙特阿拉伯首例关于一名被诊断为COVID-19阳性、康复且康复后免受再次感染的患者的病例报告。
